BrightSpring Forward P/E 30.5, PEG 0.65 Secures B Value Grade
BrightSpring Health Services holds a Zacks Rank #2 with a forward P/E of 30.54, PEG ratio of 0.65 and P/B of 4, outperforming Caris Life Sciences’ Rank #4, forward P/E 68.11, PEG 1.75 and P/B 12.15. These metrics secure BrightSpring a Value grade of B versus Caris’ D.
1. Zacks Rank and Earnings Outlook
BrightSpring Health Services carries a Zacks Rank of #2, reflecting recent positive earnings estimate revisions, while Caris Life Sciences holds a Rank of #4. This suggests analysts see stronger earnings momentum for BrightSpring over the coming quarters.
2. Valuation Metrics Comparison
BrightSpring displays a forward P/E ratio of 30.54, PEG ratio of 0.65 and P/B ratio of 4. In contrast, Caris Life Sciences shows a forward P/E of 68.11, PEG of 1.75 and P/B of 12.15, indicating a heavier valuation relative to its fundamentals.
3. Style Scores Value Grades
Based on the Style Scores system, BrightSpring earns a Value grade of B, while Caris Life Sciences is rated D. The superior grade for BrightSpring stems from its more attractive mix of P/E, PEG and P/B metrics, positioning it as the better value option.